Newsroom

MEDELLÍN, Colombia--(BUSINESS WIRE)--Mineros S.A. (TSX:MSA | BVC:MINEROS | OTCQX:MNSAF) (“Mineros” or the “Company”) reports the results of the ordinary meeting of its General Shareholders Assembly (the “Meeting”) held on Friday, March 27, 2026, in Medellín, Colombia. Results of Ordinary Meeting of General Shareholders Assembly Profit Distribution and 2026 Dividends At the Meeting, the General Shareholders Assembly approved the distribution of the Company’s 2025 profits as set forth in Table 1...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 27.03.2026 SDVY.LN IE0001R850E1 13,979,007.00 USD 323,589,031.29 23.148  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - March 27.03.2026 MMAR.LN IE0002PPCMH6 50,002.00 USD 1,297,068.81 25.940  ...

GREENWICH, Conn.--(BUSINESS WIRE)--Ditch Technology secures US patent on behavior based marine routing, offering OEMs a production ready Behavioral Navigation engine via API....

LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its third-quarter earnings release before the opening of the market on Thursday, April 9, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time. During the call, Neogen management will provide a financial overview and business update of the company’s performance for the third-quarter of fiscal year 2026. The conference call can be accessed by...

AUSTIN, Texas--(BUSINESS WIRE)--Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced final 20-week study completion data from its randomized, head-to-head Phase 1b JADE clinical study comparing OLN324, a higher-potency, smaller-format, higher-molar dose VEGF/Ang2 bispecific antibody, to faricimab (Vabysmo®), in patients with diabetic macular edema (DME) or wet (neovascular) age-related macular degeneration...

SAN JOSE, Calif.--(BUSINESS WIRE)--Momentus Inc. (NASDAQ: MNTS) (“Momentus” or the “Company”), a U.S. commercial space company specializing in satellite technology, space transportation, and in‑orbit services, today announced the successful launch of its Vigoride 7 Orbital Service Vehicle to low‑Earth orbit aboard SpaceX’s Transporter‑16 mission. The launch marks a major milestone for the Company as it begins its most advanced on‑orbit demonstration campaign to date. The Vigoride 7 spacecraft,...

NEW YORK--(BUSINESS WIRE)--VICI Properties Inc. (NYSE: VICI) (“VICI Properties”, “VICI” or the “Company”), an experiential real estate investment trust, today announced the CAD$200.6 million / USD$144.4 million pending acquisition (the “Real Estate Transaction”) of the real estate assets of Deerfoot Inn & Casino, Great Northern Casino and two limited-service hotels that are adjacent to the Great Northern Casino (collectively, the “Portfolio”) located in Alberta, Canada, in connection with P...

NEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Blackstone (NYSE: BX) today announced the final close of Blackstone Life Sciences VI (“BXLS VI”). BXLS VI was oversubscribed and closed at its hard cap of $6.3 billion of total capital commitments. It is the largest life sciences private fund ever raised and is nearly 40% larger than its predecessor vehicle. Nicholas Galakatos, Ph.D., Global Head of Blackstone Life Sciences (“BXLS”), said, “We are grateful to the BXLS VI investors for their strong s...

MIAMI--(BUSINESS WIRE)--Avory & Co today announced the launch of AVRY, the Avory Foundational ETF, designed as a long-term core equity holding for investors seeking a forward thinking, disciplined, transparent exposure to high-quality businesses positioned for durable, secular growth. AVRY is actively managed, non-index, and intentionally concentrated, with no benchmark or cash constraints. The strategy allocates capital based on conviction and valuation rather than index weights or short-t...